Pediatrix Medical (MD) Equity Ratio (2009 - 2026)

Pediatrix Medical has disclosed Equity Ratio across 18 years of filings, most recently posting 0.42 for Q1 2026.

• In Q1 2026, Equity Ratio rose 7.2% year-over-year to 0.42; the TTM figure through Mar 2026 stood at 0.42 (up 7.2% YoY), while the FY2025 annual figure was 0.39, up 8.46% from the prior year.
• Equity Ratio grew to 0.42 in Q1 2026, from 0.39 in the prior quarter.
• Over the last five years, Equity Ratio for MD reached as high as 0.42 in Q1 2026 and fell as low as 0.35 in Q3 2024.
• The 5-year median for Equity Ratio is 0.39 (2025), against an average of 0.38.
• Annual changes were most pronounced in 2022 — Equity Ratio grew 21.33% — and 2024, when it dropped 15.24%.
• A 5-year view of Equity Ratio shows it stood at 0.38 in 2022, then grew by 0.72% to 0.38 in 2023, then declined by 7.1% to 0.36 in 2024, then increased by 8.46% to 0.39 in 2025, then advanced by 10.12% to 0.42 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.42, 0.39, and 0.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.